KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹221 Cr | ₹235 Cr | ₹222 Cr | ₹263 Cr | ₹116 Cr |
What is the latest Net Current Assets ratio of KOPRAN ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹221 Cr |
| Mar2024 | ₹235 Cr |
| Mar2023 | ₹222 Cr |
| Mar2022 | ₹263 Cr |
| Mar2021 | ₹116 Cr |
How is Net Current Assets of KOPRAN Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹221 Cr | -6.25 | |
| Mar2024 | ₹235 Cr | 6.03 | |
| Mar2023 | ₹222 Cr | -15.65 | |
| Mar2022 | ₹263 Cr | 126.46 | |
| Mar2021 | ₹116 Cr | - | |
Compare Net Current Assets of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹613.9 Cr | -1.2% | 0.8% | -28% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -1.2% |
0.8% |
-28% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses